Command Palette

Search for a command to run...

Clinical Trials · NCT05548647

Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects

CompletedPhase 4Semaglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
University of Pennsylvania
Enrollment
120
Start date
Jul 2022
Locations
1 site, United States
Primary endpoint
Ad libitum energy intake (kcal) during a buffet lunch meal (4 hrs after standardized breakfast)
View Semaglutide compound reference